- New
-
Topics
- All Categories
- Metaphysics and Epistemology
- Value Theory
- Science, Logic, and Mathematics
- Science, Logic, and Mathematics
- Logic and Philosophy of Logic
- Philosophy of Biology
- Philosophy of Cognitive Science
- Philosophy of Computing and Information
- Philosophy of Mathematics
- Philosophy of Physical Science
- Philosophy of Social Science
- Philosophy of Probability
- General Philosophy of Science
- Philosophy of Science, Misc
- History of Western Philosophy
- Philosophical Traditions
- Philosophy, Misc
- Other Academic Areas
- Journals
- Submit material
- More
Works by Emmanuelle M. Voisin
Order:
- Possible Health Technology Assessment Pathways.Mireia Espallargues Carreras, Xavier Garcia Cuscó, Rossana Alessandrello, Ramon Maspons, Alexandre Serigado, Cécile F. Rousseau, Emmanuelle M. Voisin, Enrique Morales-Orcajo & Marco Viceconti - 2024 - In Marco Viceconti & Luca Emili (eds.), Toward Good Simulation Practice: Best Practices for the Use of Computational Modelling and Simulation in the Regulatory Process of Biomedical Products. Springer Nature Switzerland. pp. 73-92.No categories
- Ethical Review of In Silico Methodologies.Cécile F. Rousseau, Emmanuelle M. Voisin, Elisabetta Poluzzi, Alexandre Serigado, Marco Viceconti & Maria Cristina Jori - 2024 - In Marco Viceconti & Luca Emili (eds.), Toward Good Simulation Practice: Best Practices for the Use of Computational Modelling and Simulation in the Regulatory Process of Biomedical Products. Springer Nature Switzerland. pp. 93-100.No categories
- Possible Qualification Pathways for In Silico Methodologies.Marco Viceconti, Alexandre Serigado, Cécile F. Rousseau & Emmanuelle M. Voisin - 2024 - In Marco Viceconti & Luca Emili (eds.), Toward Good Simulation Practice: Best Practices for the Use of Computational Modelling and Simulation in the Regulatory Process of Biomedical Products. Springer Nature Switzerland. pp. 67-72.Regulatory science is ultimately a matter of trust. You need to trust that certain evidence, when obtained with certain methodologies, is sufficient to inform about a new medical product's safety and/or efficacy.No categories
PhilPapers logo by Andrea Andrews and Meghan Driscoll.
This site uses cookies and Google Analytics (see our terms & conditions for details regarding the privacy implications). Use of this site is subject to terms & conditions.
All rights reserved by The PhilPapers Foundation
Server: philpapers-web-6686886f5-5pqs9 uwo